Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...

FARAFARA Cure FA

Edison Shedding Light on Energy Production in Diseased Cells

Back in March 2013, Dainippon Sumitomo Pharma signed a deal worth $50 million or more to Mountain View, CA-based Edison Pharmaceuticals, a developer of drugs for disorders of energy metabolism.  The big pharmaceutical company from Japan liked the results. Less than a year later, it came back for more.

The two companies have now formed a larger collaboration—worth as much as $4.2 billion to Edison—and their goal is equally large-scaled. They plan to prepare 10 new drug candidates for clinical trials within five years.

Read More: Edison Shedding Light on Energy Production in Diseased Cells


About the Author

Jen Farmer

Jen Farmer

Executive Director

SHARE

FacebookTwitterLinkedInYoutube
Event E.jpg

 

Archived in
  Scientific News


 

 

Tagged in
FARA Scientific News